Data Collection Consultation 2023

Submission Form

This is the online submission form for the Data Collection Consultation being undertaken by the College of Naturopaths of Ontario. It is recommended that before completing this form you review the overview provided on the College's website which sets out in detail the specific data sets proposed to be collected.


To be valid and considered by the College, all submissions must include the name of the person providing the feedback and, where applicable, the name of any organization that you are representing.


All feedback will be published by the College as part of the consultation program. Submissions from individuals will not be identified; however, those submitted on behalf of an organization will include the name of the organization and the name of the person submitting the feedback.

1. ABOUT YOU

Please provide your given (first) name.

Please provide your family (last) name.

Please provide an email address to which the College may send you communication or information.

Please provide a telephone number where the College can reach you during regular business hours. To adjust the country, please use the arrow key to select the correct flag.

Phone
Are you a Registrant with the College of Naturopaths of Ontario*

Please enter your four-digit College registration number.

Have you completed the requirements for the Standard of Practice for Therapeutic Prescribing?*
Organizational Representation*

Are you making a submission on behalf of an organization?

Please state the full name of the organization you are representing.


2. DATA COLLECTION CONSULTATION FEEDBACK

Please select all the sections of the proposed data collection on which you will be providing feedback. Only those sections you select will be provided on the form below.

The list of controlled acts relate only to the Standard of Practice on Therapeutic Prescribing. The list includes:

  • Administering a substance by inhalation,
  • Administering a substance by injection,
  • Prescribing a drug,
  • Dispensing a drug,
  • Compounding a drug, and
  • Selling a drug.


Please provide your feedback on this list.

Feedback on Prescribing, Dispensing, Compounding or Selling Drugs

Initially, the College will be asking Registrants to provide estimates of the number of drugs prescribed, dispensed, compounded or sold; however, within a short period of time, the College would expect to receive actual data rather than estimates.


Please provide any feedback on the proposed data to be collected around the number of drugs prescribed, dispensed, compounded or sold.

It is proposed that the data collected would include the number and types of adverse occurrences encountered in Registrants' practices. An adverse occurrence is defined as any of the following:

  • Patient referred to emergency services within 5 days,
  • An emergency drug had to be administered to the patient,
  • Patient subsequently diagnosed with shock or convulsions within 5 days,
  • Patient’s condition did not improve or worsened,
  • An unscheduled treatment had to be provided to the patient,
  • Patient had adverse drug reaction.


Please provide your feedback on the questions relating to the number and types of adverse occurrences identified. Are these relevant? Are there adverse occurrences that should be added?

Feedback on Administering a Substance by Injection

Initially, the College will be asking Registrants to provide estimates of the number of substances administered by injection to patients; however, within a short period of time, the College would expect to receive actual data rather than estimates.


Please provide any feedback on the proposed data to be collected around the number of substances administered by injection to patients.

It is proposed that the data collected would include the number and types of adverse occurrences when administering substances by injection encountered in Registrants' practices. An adverse occurrence is defined as any of the following:

  • Patient referred to emergency services within 5 days,
  • An emergency drug had to be administered to the patient,
  • Patient subsequently diagnosed with shock or convulsions within 5 days,
  • Patient’s condition did not improve or worsened,
  • An unscheduled treatment had to be provided to the patient,
  • Patient had adverse substance reaction.


Please provide your feedback on the questions relating to the number and types of adverse occurrences identified. Are these relevant? Are there adverse occurrences that should be added?

Feedback on Administering a Substance by Inhalation

Initially, the College will be asking Registrants to provide estimates of the number of substances administered by inhalation to patients; however, within a short period of time, the College would expect to receive actual data rather than estimates.


Please provide any feedback on the proposed data to be collected around the number of substances administered by inhalation to patients.

It is proposed that the data collected would include the number and types of adverse occurrences when administering substances by inhalation encountered in Registrants' practices. An adverse occurrence is defined as any of the following:

  • Patient referred to emergency services within 5 days,
  • An emergency drug had to be administered to the patient,
  • Patient subsequently diagnosed with shock or convulsions within 5 days,
  • Patient’s condition did not improve or worsened,
  • An unscheduled treatment had to be provided to the patient,
  • Patient had adverse substance reaction.


Please provide your feedback on the questions relating to the number and types of adverse occurrences identified. Are these relevant? Are there adverse occurrences that should be added?

Feedback on Additional Data Sets

For each of the sections in the data being collected, Registrants who report an adverse occurrence of an unscheduled treatment will be asked to identify the types of conditions encountered that required treatment. The types conditions identified in the data set are:

  • Anxiety
  • Dizziness
  • Headache
  • Fatigue
  • Injection site extravasation (only for injections)
  • Low back strain
  • Muscular spasms
  • Pain at injection site (only for injections)
  • Phlebitis
  • Pneumonia.


Please provide your feedback on the types of conditions infections identified. Is the list complete? Are their conditions included that are not relevant (considering each of the controlled acts) and are their conditions commonly encountered that are missing (considering each of the controlled acts).

For each of the sections in the data being collected, Registrants who report an adverse drug/substance occurrence will be asked to identify the types of adverse reactions encountered. The types adverse reactions to drugs or substances identified in the data set are:

  • Anxiety
  • Diarrhea
  • Headache
  • Hypertension
  • Hypoglycemia
  • Injection site extravasation
  • Maculo-papular rash
  • Nausea
  • Phlebitis
  • Pre-syncope
  • Seizure
  • Shortness of breath
  • Syncope
  • Urticaria
  • Vomiting


Please provide your feedback on the types of adverse drug/substance reactions identified. Is the list complete? Are their adverse reactions included that are not relevant (considering each of the controlled acts) and are their adverse reactions commonly encountered that are missing (considering each of the controlled acts).

General Feedback

If you have taken the opportunity to view the mock up of the on-line for for use in data collection, please provide any feedback that you may have.

While it is not intended that this process be punitive in nature, the only means the College has to collect this data is to require that it be submitted in accordance with the by-laws. Additionally, the data will only be usable it is can be relied upon as a window on all Registrants who perform these controlled acts.


This will also mean that the College will be required to follow up with Registrants who do not provide the data and that the potential for an administrative suspension might occur. The College is hopeful that the intent of the data and how it will be used will be sufficient enticement to support this initiative.


We welcome your feedback.

Please feel free to provide any additional comments that you would like to provide.


3. DECLARATION AND SIGNATURE

Declaration*

I declare that the information that I have submitted is true and represents my own personal opinion or that of the organization that I am submitting on behalf of.

Signature


By checking the box below, you are affixing a signature to this form and indicating that this form and the information contained herein is bound directly to you.


4. COPY OF SUBMISSION

Below is a check box to enable you to receive a copy of your submission. It is highly recommended that you check this box and enter your e-mail address. This will enable the on-line system to send you a copy of the information that you have provided to the College.


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.